These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 12878529

  • 1. Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.
    Foster WK, Miller DS, Marion PL, Colonno RJ, Kotlarski I, Jilbert AR.
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2624-35. PubMed ID: 12878529
    [Abstract] [Full Text] [Related]

  • 2. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS, Boyle D, Feng F, Reaiche GY, Kotlarski I, Colonno R, Jilbert AR.
    Virology; 2008 Apr 10; 373(2):329-41. PubMed ID: 18206204
    [Abstract] [Full Text] [Related]

  • 3. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
    Foster WK, Miller DS, Scougall CA, Kotlarski I, Colonno RJ, Jilbert AR.
    J Virol; 2005 May 10; 79(9):5819-32. PubMed ID: 15827196
    [Abstract] [Full Text] [Related]

  • 4. The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines.
    Feng F, Teoh CQ, Qiao Q, Boyle D, Jilbert AR.
    Vaccine; 2010 Oct 28; 28(46):7436-43. PubMed ID: 20833122
    [Abstract] [Full Text] [Related]

  • 5. Potent efficacy of entecavir (BMS-200475) in a duck model of hepatitis B virus replication.
    Marion PL, Salazar FH, Winters MA, Colonno RJ.
    Antimicrob Agents Chemother; 2002 Jan 28; 46(1):82-8. PubMed ID: 11751115
    [Abstract] [Full Text] [Related]

  • 6. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A, Locarnini S, Chou ST, Smallwood R, Angus P.
    J Gastroenterol Hepatol; 2000 Mar 28; 15(3):304-10. PubMed ID: 10764033
    [Abstract] [Full Text] [Related]

  • 7. Antiviral effects of PNA in duck hepatitis B virus infection model.
    Chen ZY, Cheng AC, Wang MS, Xu DW, Zeng W, Li Z.
    Acta Pharmacol Sin; 2007 Oct 28; 28(10):1652-8. PubMed ID: 17883953
    [Abstract] [Full Text] [Related]

  • 8. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
    Miller DS, Kotlarski I, Jilbert AR.
    Virology; 2006 Jul 20; 351(1):159-69. PubMed ID: 16624364
    [Abstract] [Full Text] [Related]

  • 9. Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks.
    Quinet J, Jamard C, Burtin M, Lemasson M, Guerret S, Sureau C, Vaillant A, Cova L.
    Hepatology; 2018 Jun 20; 67(6):2127-2140. PubMed ID: 29251788
    [Abstract] [Full Text] [Related]

  • 10. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
    Miller DS, Halpern M, Kotlarski I, Jilbert AR.
    Virology; 2006 May 10; 348(2):297-308. PubMed ID: 16469347
    [Abstract] [Full Text] [Related]

  • 11. Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.
    Le Guerhier F, Thermet A, Guerret S, Chevallier M, Jamard C, Gibbs CS, Trépo C, Cova L, Zoulim F.
    J Hepatol; 2003 Mar 10; 38(3):328-34. PubMed ID: 12586299
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.
    Noordeen F, Scougall CA, Grosse A, Qiao Q, Ajilian BB, Reaiche-Miller G, Finnie J, Werner M, Broering R, Schlaak JF, Vaillant A, Jilbert AR.
    PLoS One; 2015 Mar 10; 10(11):e0140909. PubMed ID: 26560490
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Duck hepatitis B virus (DHBV) infection in Indian domestic ducks: a pilot study.
    Sridhar G, Valliammai T, Varalakshmi CS, Udayasankar K, Panchanadam M, Ramakrishna J, Gopal KV, Jayaraman K, Thyagarajan SP.
    Trop Anim Health Prod; 1993 Nov 10; 25(4):229-33. PubMed ID: 8109057
    [Abstract] [Full Text] [Related]

  • 18. In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes.
    Saade F, Buronfosse T, Guerret S, Pradat P, Chevallier M, Zoulim F, Jamard C, Cova L.
    J Viral Hepat; 2013 Apr 10; 20(4):e56-65. PubMed ID: 23490390
    [Abstract] [Full Text] [Related]

  • 19. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
    Tomita T, Yokosuka O, Tagawa M, Saisho H, Tamura S, Fukuda I, Omata M.
    J Hepatol; 2000 May 10; 32(5):850-8. PubMed ID: 10845674
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.